(S)-Benzyl (4-(2,5-dioxooxazolidin-4-yl)butyl)carbamate, 95.0%, 25g

(4,6-Dichloropyridin-3-yl)(4-fluorophenyl)methanone, 98%, 250mg

Ethyl (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, 95%, 5g

4(5)-Cyanomethylimidazole>99.0%(GC)(T)5g

(S)-4,4'-Bis(diphenylphosphino)-2,2',6,6'-tetramethoxy-3,3'-bipyridine, 98%, 50mg

3-Chloro-1H-pyrazolo[3,4-c]pyridine, 95.0%, 250mg

Disposable syringe Injekt® With Luer Lock connection, 2 ml, 100 pieces

4-[benzyl(tert-butoxycarbonyl)amino]butanoic acid, 95.0%, 10g

7-methyl[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid, 95.0%, 250mg

2-Bromo-1,1-difluorocyclopentane, 97%, 100mg

5-(3-Bromophenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

6-Bromo-4-iodo-1H-indole, 95.0%, 100mg

Extraction system BioChemVacuuCenter BVC Model Control, BVC Control G, 2 l glass collection bottle, with hose connections, 1 piece